Bilaal.Raja
Company record

QTRX  Quanterix Corp

Trailing twelve months to 2026-06-30, as filed 2026-08-10 and not restated since.
Healthcare

Scale

Market cap
$172m
Revenue TTM
$153m
Net income TTM
$-123m
Free cash flow
$-82m
Composite score
39.1
Sector rank
#2885

Valuation

P / E
—
EV / EBITDA
—
EV / sales
0.5
FCF yield
-47.45%
Yield vs 10-yr
-76.79pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 5.28% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-80.2%
EBITDA margin
-84.4%
ROE
-51.9%
ROIC
-106.4%
Revenue growth
22.0%

Insider activity, last 90 days

Net open-market
$0.29m
Buyers
1
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

As the installed base of our instruments increases, we expect total consumables revenue to increase. Change in Accounting Principle During the first quarter of 2026 we changed our accounting policy for classifying shipping and handling costs for product sales, which are primarily comprised of costs paid to third-party shippers for transporting products to customers. Comparison of Results of Operations for the Three Months Ended June 30, 2026 and 2025: The following table sets forth select Consolidated Statements of Operations data, and such data as a percentage of total revenues (in thousands, except percentages): Revenues Total revenues increased $8.4 million, or 34%, to $32.9 million for t …Quanterix Corp, 10-Q, period ended 2026-06-30, filed 2026-08-10

Read the full passage →